Jillian N Noblet1, Meredith K Owen1, Adam G Goodwill1, Daniel J Sassoon1, Johnathan D Tune2. 1. From the Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis (J.N.N., A.G.G., D.J.S., J.D.T.); and Department of Cell Biology and Physiology, University of North Carolina School of Medicine, Chapel Hill (M.K.O.). 2. From the Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis (J.N.N., A.G.G., D.J.S., J.D.T.); and Department of Cell Biology and Physiology, University of North Carolina School of Medicine, Chapel Hill (M.K.O.). jtune@iu.edu.
Abstract
OBJECTIVE: The effects of coronary perivascular adipose tissue (PVAT) on vasomotor tone are influenced by an obese phenotype and are distinct from other adipose tissue depots. The purpose of this investigation was to examine the effects of lean and obese coronary PVAT on end-effector mechanisms of coronary vasodilation and to identify potential factors involved. APPROACH AND RESULTS: Hematoxylin and eosin staining revealed similarities in coronary perivascular adipocyte size between lean and obese Ossabaw swine. Isometric tension studies of isolated coronary arteries from Ossabaw swine revealed that factors derived from lean and obese coronary PVAT attenuated vasodilation to adenosine. Lean coronary PVAT inhibited K(Ca) and KV7, but not KATP channel-mediated dilation in lean arteries. In the absence of PVAT, vasodilation to K(Ca) and KV7 channel activation was impaired in obese arteries relative to lean arteries. Obese PVAT had no effect on K(Ca) or KV7 channel-mediated dilation in obese arteries. In contrast, obese PVAT inhibited KATP channel-mediated dilation in both lean and obese arteries. The differential effects of obese versus lean PVAT were not associated with changes in either coronary KV7 or K(ATP) channel expression. Incubation with calpastatin attenuated coronary vasodilation to adenosine in lean but not in obese arteries. CONCLUSIONS: These findings indicate that lean and obese coronary PVAT attenuates vasodilation via inhibitory effects on vascular smooth muscle K(+) channels and that alterations in specific factors such as calpastatin are capable of contributing to the initiation or progression of smooth muscle dysfunction in obesity.
OBJECTIVE: The effects of coronary perivascular adipose tissue (PVAT) on vasomotor tone are influenced by an obese phenotype and are distinct from other adipose tissue depots. The purpose of this investigation was to examine the effects of lean and obese coronary PVAT on end-effector mechanisms of coronary vasodilation and to identify potential factors involved. APPROACH AND RESULTS:Hematoxylin and eosin staining revealed similarities in coronary perivascular adipocyte size between lean and obese Ossabaw swine. Isometric tension studies of isolated coronary arteries from Ossabaw swine revealed that factors derived from lean and obese coronary PVAT attenuated vasodilation to adenosine. Lean coronary PVAT inhibited K(Ca) and KV7, but not KATP channel-mediated dilation in lean arteries. In the absence of PVAT, vasodilation to K(Ca) and KV7 channel activation was impaired in obese arteries relative to lean arteries. Obese PVAT had no effect on K(Ca) or KV7 channel-mediated dilation in obese arteries. In contrast, obese PVAT inhibited KATP channel-mediated dilation in both lean and obese arteries. The differential effects of obese versus lean PVAT were not associated with changes in either coronary KV7 or K(ATP) channel expression. Incubation with calpastatin attenuated coronary vasodilation to adenosine in lean but not in obese arteries. CONCLUSIONS: These findings indicate that lean and obese coronary PVAT attenuates vasodilation via inhibitory effects on vascular smooth muscle K(+) channels and that alterations in specific factors such as calpastatin are capable of contributing to the initiation or progression of smooth muscle dysfunction in obesity.
Authors: Beatriz Gálvez; Javier de Castro; Diana Herold; Galyna Dubrovska; Silvia Arribas; M Carmen González; Isabel Aranguez; Friedrich C Luft; M Pilar Ramos; Maik Gollasch; Maria S Fernández Alfonso Journal: Arterioscler Thromb Vasc Biol Date: 2006-04-06 Impact factor: 8.311
Authors: Gregory A Payne; Léna Borbouse; Ian N Bratz; William C Roell; H Glenn Bohlen; Gregory M Dick; Johnathan D Tune Journal: Microcirculation Date: 2008-07 Impact factor: 2.628
Authors: Matthew S Reifenberger; James R Turk; Sean C Newcomer; Frank W Booth; M Harold Laughlin Journal: Med Sci Sports Exerc Date: 2007-12 Impact factor: 5.411
Authors: Marcin Malinowski; Marek A Deja; Krzysztof S Gołba; Tomasz Roleder; Jolanta Biernat; Stanisław Woś Journal: Eur J Cardiothorac Surg Date: 2007-12-20 Impact factor: 4.191
Authors: Maloree Khan; Alex I Meuth; Scott M Brown; Bysani Chandrasekar; Douglas K Bowles; Shawn B Bender Journal: Am J Physiol Heart Circ Physiol Date: 2019-06-14 Impact factor: 4.733
Authors: Mikaela L McKenney-Drake; Stacey D Rodenbeck; Rebecca S Bruning; Ayeeshik Kole; Kyle W Yancey; Mouhamad Alloosh; Harold S Sacks; Michael Sturek Journal: Ann Thorac Surg Date: 2017-02-21 Impact factor: 4.330
Authors: Jillian N Noblet; Adam G Goodwill; Daniel J Sassoon; Alexander M Kiel; Johnathan D Tune Journal: Basic Res Cardiol Date: 2016-03-14 Impact factor: 17.165
Authors: Shuangtao Ma; Xiang-Yang Zhu; Alfonso Eirin; John R Woollard; Kyra L Jordan; Hui Tang; Amir Lerman; Lilach O Lerman Journal: J Urol Date: 2015-09-28 Impact factor: 7.450